Sanofi Pasteur news from FierceVaccines
NewsSanofi licenses technology for new TB vaccine
Sanofi Pasteur has struck a licensing deal with the Statens Serum Institut of Denmark covering the use of its technology for a new tuberculosis vaccine. The pact includes SSI's Intercell IC31 Read more...
| Press ReleasesCrucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals against Rabies Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals against Rabies Exclusive agreement for rabies monoclonal antibodies to fight fatal disease Leiden, The Netherlands, 3 Read more... PRESS RELEASE: Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 1 - No Human Vaccine Currently Exists Against the West Nile Read more... |
Get more Sanofi Pasteur coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight